Search results
Abbott (ABT) Rises Higher Than Market: Key Facts
Zacks via Yahoo Finance· 5 months agoAbbott (ABT) closed the latest trading day at $108.06, indicating a +0.72% change from the previous session's end. This change outpaced the S&P 500's...
RI to pay consulting firm $339K for new state affordable housing plan
The Providence Journal via Yahoo News· 8 months agoPROVIDENCE - Get ready for another big report, or two, on how to make homes more affordable in Rhode...
Abbott (ABT) Debuts Amplatzer Talisman System in Europe
Zacks via Yahoo Finance· 2 years agoAbbott's (ABT) Amplatzer Talisman PFO Occlusion System will enable doctors across Europe to treat...
The Abbott Laboratories (ABT) Company: A Short SWOT Analysis
GuruFocus.com via Yahoo Finance· 7 months agoAbbott Laboratories (NYSE:ABT) exhibits strong global presence with diverse product portfolio. The...
Abbott's (ABT) New Positive Data Favors OCT in Stent Implantation
Zacks via Yahoo Finance· 9 months agoAbbott Laboratories ABT recently announced late-breaking data from the first-of-its-kind ILUMIEN IV...
Abbott (ABT) to Offer New Treatment Option for Chronic Pain
Zacks via Yahoo Finance· 2 years agoAbbott Laboratories ABT recently received FDA approval for its novel Proclaim Plus spinal cord...
Abbott's (ABT) Q2 Earnings Top Estimates, '22 EPS View Up
Zacks via Yahoo Finance· 2 years agoAbbott (ABT) reports better-than-expected results for Q2 2022, with robust contributions from the...
Abbott (ABT) to Expand Vascular Device Line With New Buyout
Zacks via Yahoo Finance· 1 year agoAbbott Laboratories, Inc. ABT recently entered into a definitive agreement to acquire Cardiovascular...
Abbott's (ABT) Eterna SCS System Receives FDA's Approval
Zacks via Yahoo Finance· 1 year agoAbbott Laboratories ABT recently received FDA approval for its Eterna spinal cord stimulation (SCS)...
11 Best S&P 500 Stocks To Buy According to Ray Dalio’s Bridgewater Associates
Insider Monkey via Yahoo Finance· 7 months agoIn this article, we discuss the 11 best S&P 500 stocks to buy according to Bridgewater Associates....